Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

CT scan

Merck and Pfizer kick off Phase III avelumab cancer trials

December 23, 2015 Research and Development Merck, Pfizer, avelumab, ovarian cancer

Merck and Pfizer have announced the opening of trial sites for an international Phase III study of avelumab in patients …
News
Actelion building

Actelion ready to launch Uptravi after FDA approval

December 22, 2015 Research and Development, Sales and Marketing Actelion, FDA, Jean-Paul Clozel, Uptravi, pulmonary arterial hypertension, selexipag

Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …
News
Flemming Ornskov

Shire moves to seal Baxalta deal with improved offer

December 22, 2015 Research and Development, Sales and Marketing Baxalta, Flemming Ornskov, Shire

Shire is set to sweeten its $30 billion bid for Baxalta by offering 40% of the total, or $12 billion, …
News

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …
Appointment
Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015 Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …
News

Novartis completes purchase of rights to GSK drug for up to $1bn

December 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …
News
ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …
Appointment
tim-walbert

Horizon chief exec Walbert to head up US biotech trade body

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois

Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …
Appointment
landing-hero-images1

ViiV Healthcare to acquire Bristol-Myers Squibb’s HIV pipeline drugs

December 18, 2015 Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, HIV, ViiV, ViiV Healthcare

Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …
News
National Institutes of Health building

Clinical trials increasingly funded by pharma industry

December 17, 2015 Research and Development JAMA, Journal of the American Medical Association, NIH, National Institutes of Health, clinical trials, clinicaltrials.gov, pharma, research

The number of clinical trials funded by pharma has risen significantly since 2006, while the number funded by the US …
News
csm_297_1444449899_5ce719038f

US ‘star’ Bradner to head Novartis Institute of Biomedical Research

December 17, 2015 Research and Development James Bradner, Jay Bradner, Mark Fishman, Novartis, Novartis Institute for Biomedical Research

Novartis has hired James ‘Jay’ Bradner, from Harvard’s Dana-Farber Cancer Institute, to head its Institutes for Biomedical Research from 1 …
Appointment
Sovaldi bottle

Gilead’s Sovaldi wins Drug Discovery of the Year Award

December 16, 2015 Research and Development British Pharmacological Society, Gilead, Gilead Sciences, hepatitis C, sofosbuvir, sovaldi

Gilead Science’s hepatitis C treatment Sovaldi has been awarded the British Pharmacological Society’s prestigious Drug Discovery of the Year 2016. …
News
Return on investment

Analysts say pharma R&D returns challenged by drag of high costs

December 16, 2015 Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts

The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …
News

AstraZeneca to acquire Takeda’s respiratory franchise

December 16, 2015 Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory

AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …
News
clinical_trial-web

Pharma deals crucial to cutting R&D costs

December 16, 2015 Research and Development GlobalData, R&D, drug development, pharma, research and development

With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026